Welcome to 21st-century professional health-care education!  From your own city, with 2000 colleagues from around the country, you will participate in a program conducted by some of the nation’s most-recognized experts in women’s cardiovascular health. Beaming from the originating site in Baltimore, MD, you’ll be able to interact ‘real-time’ with our 4 experts, who will deliver live presentations and answer your questions—from Florida to New England to Arizona to Seattle! 

Using satellite technology and 2-way telephone transmissions, you’ll be “live” without having to travel from your home city. And you’ll be part of a national program, with thousands of your colleagues, gaining insights and answers to the questions and challenges you face every day in caring for women with car-dio- and peripheral-vascular disease. In addition, this program will be presented in cooperation with other leading academic centers—a testament to the timeliness and outstanding content of the program.

We look forward to having you join us!

Heart disease was once considered a man’s problem. But according to the American Medical Association (AMA), cardiovascular disease is also the number one killer of women. For years, it was thought that women were not as susceptible to heart disease as men. The initial results of an ongoing study, started in 1948 in Framingham, Massachusetts, were published in the 50s and showed men more likely to have heart disease. But as time progressed, it was discovered that women also were at risk; they just developed diseases of the heart 10 to 15 years later than men.

The prevalence of peripheral arterial disease is higher in women than in men; about 11.4% to 20.5% in women older than 55 years. Overall mortality after the diagnosis of peripheral arterial disease is about 30% after 5 years and 70% after 15 years.

The American Heart Association estimates that 1 in 9 women ages 45 to 64 have some sort of heart disease, but the ratio jumps to 1 in 3 for women over 65. It’s essential that women as well as men, especially those with a family history of heart disease, adopt a heart-healthy lifestyle and maintain it as they get older. The goal of this program is to raise awareness of the prevalence and entwined nature of CVD/PVD in women. With the new information applied to the prevention, diagnosis, and management of these conditions women face, they will finally be better identified and cared for. It is incumbent on the healthcare provider to be educated on the newest research findings and to take the actions necessary to protect women’s hearts!

Intended Audience:
This activity is designed for physicians, PAs, NPs, nurses, and pharmacists. There are no prerequisites for attendees.

At the conclusion of this education activity, the participant should be able to:

• Identify and assess cardiovascular disease risk in women.
• Review diagnostic studies used to assess CVD/PVD risk in women.
• Compare and contrast how peripheral arterial disease and peripheral vascular disease affect women.
• Identify the types of patients to refer for cardiac or vascular follow-up.
• Discuss the management of heart failure in women.
• Classify secondary prevention, assess risk, and implement the latest treatment plans.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and University of Tennessee College of Pharmacy. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s).™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

This 3.6 contact hour Educational Activity (Provider Directed) is provided by The Institute for Johns Hopkins Nursing. Each participant should claim only those contact hours that he/she actually spent in the activity.

This program is approved for 3 hours of credit (0.3 CEUs) and is sponsored by the University of Tennessee College of Pharmacy who is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Program# 064-000-06-207-L01.

1:00 pm-1:05 pm EST
Introduction -- Roger S. Blumenthal, MD, FACC

1:05 pm-1:35 pm EST
Cardiovascular Disease in Women -- Rita Redberg, MD

1:35 pm-2:00 pm EST
Questions and Answers

2:00 pm-2:30 pm EST   
Heart Failure in Women -- Ilan S. Wittstein, MD

2:30 pm-3:00 pm EST   
Questions and Answers

3:00 pm-3:30 pm EST   
Peripheral Arterial Disease and Peripheral Vascular Disease in Women -- Emile R. Mohler, III, MD

3:30 pm-3:55 pm EST   
Questions and Answers

3:55 pm-4:00 pm EST   
Final Remarks -- Roger S. Blumenthal, MD

Roger S. Blumenthal, MD, FACC* † (Chairperson)
Associate Professor of Medicine/Cardiology
Director, Johns Hopkins Ciccarone Preventive Cardiology Center
Baltimore, MD

M. Dominique Ashen, PhD, CRNP*
Nurse Practitioner
Johns Hopkins Ciccarone Preventive Cardiology Center
The Johns Hopkins Hospital
Baltimore, MD

Paula Adina Johnson, MD*
Executive Director of the Connors
Center for Women’s Health and Gender Biology
Brigham and Women’s Hospital
Department of Medicine
Chief-Women’s Health Division
Boston, MA

Beth R. Malasky, MD, FACC*
Clinical Assistant Professor of Medicine
Native American Cardiology Program
University of Arizona Health Sciences Center
University Medical Center
Tucson, AZ

Emile R. Mohler, III, MD †
Director, Vascular Medicine
Associate Professor of Medicine
University of Pennsylvania Health System
Philadelphia, PA

Mark W. Moritz, MD, FACS*
Clinical Professor of Vascular Surgery
University of Medicine and Dentistry of New Jersey
Vein Institute of New Jersey
Morristown, NJ

Ileana L. Piña, MD*
Professor of Medicine
Case Western Reserve University
Heart Failure and Transplantation Quality Scholar
Louis Stokes VA Medical Center
Cleveland, OH

Rita Redberg, MD* †
Professor of Medicine
University of California
San Francisco Division of Cardiology
San Francisco, CA

Mary Norine Walsh, MD, FACC*
Director, Heart Failure Program
The Care Group, LLC
Indianapolis, IN

Nanette K.Wenger, MD, MACP, FACC, FAHA*
Professor of Medicine
Division of Cardiology
Emory University School of Medicine
Chief of Cardiology
Grady Memorial Hospital
Atlanta, GA

Ilan S.Wittstein, MD †
Assistant Professor of Medicine
Johns Hopkins Hospital
Baltimore, MD

* These faculty members are a part of the steering committee.
† These faculty members will be the broadcast speakers.

It is the policy of the Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME and The Institute for Johns Hopkins Nursing has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the course handout materials. Americans With Disabilities Act: The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing fully comply with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs..

The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing fully comply with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Supported by an educational grant from
Pfizer Inc.